查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1975284

2026-2034年牛暫緩發熱疫苗全球市場規模、佔有率、趨勢和成長分析報告

Global Bovine Ephemeral Fever Vaccines Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 137 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計牛傳染性發燒疫苗市場規模將從 2025 年的 8,274 萬美元成長到 2034 年的 1.1494 億美元，2026 年至 2034 年的複合年成長率為 3.72%。

由於牛疾病發生率不斷上升以及人們對動物健康管理的意識提升，牛暫時性發燒（TSF）疫苗的全球市場正蓬勃發展。 TSF（俗稱三日熱）對牛的生產力影響巨大，導致酪農和畜牧業遭受經濟損失。對優質動物性蛋白質需求的成長以及畜群管理實踐的改進正在推動全球疫苗的普及應用。

政府主導的牲畜疫苗接種計劃和獸醫學的進步是市場的主要驅動力。在酪農產業不斷發展的開發中國家，為確保穩定生產，對動物預防保健的投資正在增加。人們對糧食安全和永續畜牧業日益成長的關注進一步推動了疫苗接種計劃的發展。製藥公司正在投資研發改良的疫苗配方，以提高疫苗效力並延長免疫持續時間。

預計未來成長將主要得益於畜牧業商業化進程的推進和數位化動物健康監測系統的整合。氣候變遷和媒介傳播疾病的蔓延可能會凸顯預防性疫苗接種策略的重要性。加強分銷網路將透過擴大獸醫基礎設施和強化公私合營來實現。隨著全球對安全、優質動物產品的需求持續成長，市場可望保持穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球牛暫症發熱疫苗市場：依疫苗類型分類

  • 市場分析、洞察與預測
  • 活病毒疫苗
  • 去活化疫苗
  • 其他

第5章 全球牛暫緩發熱疫苗市場：依應用分類

  • 市場分析、洞察與預測
  • 牛
  • 水牛

第6章 全球牛暫緩發熱疫苗市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫療設備製造商
  • 製藥業
  • 動物醫院
  • 其他最終用戶

第7章 全球牛暫緩發熱疫苗市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 亞太其他地區
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Zoetis Services LLC
    • Nutri Pharmax Sdn Bhd
    • Octavoscene（Pty）Ltd
    • Kyoto Biken Laboratories Inc
    • Indian Immunologicals Ltd
    • CAVAC Network
    • Onderstepoort Biological Products SOC Ltd
    • Green Cross Veterinary Products Co. Ltd
    • Veterinary Serum & Vaccine Research Institute
    • Boehringer Ingelheim International GmbH
簡介目錄
Product Code: VMR112112314

The Bovine Ephemeral Fever Vaccines Market size is expected to reach USD 114.94 Million in 2034 from USD 82.74 Million (2025) growing at a CAGR of 3.72% during 2026-2034.

The Global Bovine Ephemeral Fever Vaccines Market is gaining momentum due to increasing livestock disease outbreaks and rising awareness about animal health management. Bovine ephemeral fever, commonly known as three-day sickness, significantly impacts cattle productivity, leading to economic losses in dairy and meat industries. Growing demand for quality animal protein and improved herd management practices are driving vaccination adoption worldwide.

Government-led livestock immunization programs and veterinary healthcare advancements are key market drivers. Developing countries with expanding dairy sectors are increasingly investing in preventive animal healthcare to ensure stable production. Rising focus on food security and sustainable livestock farming is further encouraging vaccination programs. Pharmaceutical companies are investing in improved vaccine formulations with enhanced efficacy and longer immunity duration.

Future growth is expected to be supported by increasing commercialization of livestock farming and the integration of digital animal health monitoring systems. Climate change and vector-borne disease spread may elevate the importance of preventive vaccination strategies. Expanding veterinary infrastructure and public-private partnerships will strengthen distribution networks. The market is poised for steady growth as global demand for safe and high-quality animal products continues to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Vaccine Type

  • Live Vaccine
  • Killed Vaccine
  • Others

By Application

  • Cattle
  • Water Buffaloes

By End Users

  • Medical Device Companies
  • Pharmaceutical Industries
  • Animal Hospitals
  • Other End Users

COMPANIES PROFILED

  • Zoetis Services LLC, Nutri Pharmax Sdn Bhd, Octavoscene Pty Ltd, Kyoto Biken Laboratories Inc, Indian Immunologicals Ltd, CAVAC Network, Onderstepoort Biological Products SOC Ltd, Green Cross Veterinary Products Co Ltd, Veterinary Serum Vaccine Research Institute, Boehringer Ingelheim International GmbH
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET: BY VACCINE TYPE 2022-2034 (USD MN and Million Doses)

  • 4.1. Market Analysis, Insights and Forecast Vaccine Type
  • 4.2. Live Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.3. Killed Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET: BY APPLICATION 2022-2034 (USD MN and Million Doses)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Cattle Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.3. Water Buffaloes Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET: BY END USERS 2022-2034 (USD MN and Million Doses)

  • 6.1. Market Analysis, Insights and Forecast End Users
  • 6.2. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.3. Pharmaceutical Industries Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.4. Animal Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL BOVINE EPHEMERAL FEVER VACCINES MARKET: BY REGION 2022-2034(USD MN and Million Doses)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.2.1 By Vaccine Type
    • 7.2.2 By Application
    • 7.2.3 By End Users
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.3.1 By Vaccine Type
    • 7.3.2 By Application
    • 7.3.3 By End Users
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.4.1 By Vaccine Type
    • 7.4.2 By Application
    • 7.4.3 By End Users
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.5.1 By Vaccine Type
    • 7.5.2 By Application
    • 7.5.3 By End Users
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 7.6.1 By Vaccine Type
    • 7.6.2 By Application
    • 7.6.3 By End Users
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BOVINE EPHEMERAL FEVER VACCINES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Zoetis Services LLC
    • 9.2.2 Nutri Pharmax Sdn Bhd
    • 9.2.3 Octavoscene (Pty) Ltd
    • 9.2.4 Kyoto Biken Laboratories Inc
    • 9.2.5 Indian Immunologicals Ltd
    • 9.2.6 CAVAC Network
    • 9.2.7 Onderstepoort Biological Products SOC Ltd
    • 9.2.8 Green Cross Veterinary Products Co. Ltd
    • 9.2.9 Veterinary Serum & Vaccine Research Institute
    • 9.2.10 Boehringer Ingelheim International GmbH